Open-label phase II study of S-1 as second-line therapy for patients with advanced non-small cell lung cancer (NSCLC).

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 7580-7580 ◽  
Author(s):  
R. Govindan ◽  
C. Zergebel ◽  
K. Saito ◽  
J. H. Schiller
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Open Label ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Open Label Phase

Phase II study of cabazitaxel as second-line therapy in stage IV non-small cell lung cancer (NSCLC).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. e19107-e19107
Author(s):  
Devika Das ◽  
Francisco Robert ◽  
Rodolfo Bordoni ◽  
Stefan C. Grant ◽  
Mansoor N. Saleh ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Stage Iv ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy

Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer

Lung Cancer ◽  
2009 ◽  
Vol 64 (1) ◽  
pp. 60-65 ◽  
Author(s):  
Tim Eisen ◽  
Nick Thatcher ◽  
Serge Leyvraz ◽  
Wilson H. Miller ◽  
Felix Couture ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy

A phase II study of KOS-862 (epothilone D) as second-line therapy in non-small cell lung cancer

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7127-7127 ◽  
Author(s):  
L. Yee ◽  
T. Lynch ◽  
M. Villalona-Calero ◽  
N. Rizvi ◽  
N. Gabrail ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Epothilone D
Sign in / Sign up

Export Citation Format

Share Document